| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-19312 |
3-Methyladenine |
Inhibitor |
99.91% |
Unkown |
| HY-P0175 |
740 Y-P |
|
99.67% |
Unkown |
| HY-10197 |
Wortmannin |
Inhibitor |
99.86% |
Unkown |
| HY-12016 |
KU-55933 |
Inhibitor |
99.92% |
Unkown |
| HY-N0728 |
α-Linolenic acid |
Inhibitor |
99.92% |
Unkown |
| HY-11006 |
KU-57788 |
Inhibitor |
99.95% |
Unkown |
| HY-13002 |
Torin 2 |
|
99.69% |
Unkown |
| HY-N0776 |
Isorhamnetin |
Inhibitor |
99.94% |
Unkown |
| HY-156681 |
Tersolisib |
Inhibitor |
99.77% |
Unkown |
| HY-12795 |
Vps34-IN-1 |
|
99.79% |
Unkown |
| HY-154848 |
UCL-TRO-1938 |
Activator |
99.98% |
Unkown |
| HY-10115 |
PI-103 |
|
99.82% |
Unkown |
| HY-113402 |
Gamma-glutamylcysteine |
|
98.53% |
Unkown |
| HY-124719 |
hSMG-1 inhibitor 11j |
Inhibitor |
99.82% |
Unkown |
| HY-D0254 |
Gallein |
|
98.0% |
Unkown |
| HY-100355 |
C18-Ceramide (d18:1/18:0) |
|
99.95% |
Unkown |
| HY-P1410B |
D-GsMTx4 |
Inhibitor |
99.44% |
Unkown |
| HY-N0451 |
Acacetin |
Inducer |
99.71% |
Unkown |
| HY-110171 |
iMDK |
Inhibitor |
99.35% |
Unkown |
| HY-N0143 |
Phlorizin |
|
99.93% |
Unkown |
| HY-153306 |
Zovegalisib |
Inhibitor |
98.80% |
Unkown |
| HY-10108A |
LY294002 hydrochloride |
|
99.97% |
Unkown |
| HY-N0022 |
Isoacteoside |
|
99.73% |
Unkown |
| HY-144806 |
PI3K/AKT-IN-1 |
|
99.64% |
Unkown |
| HY-113308A |
Taurolithocholic acid sodium salt |
|
99.81% |
Unkown |
| HY-N0270 |
Ononin |
|
99.88% |
Unkown |
| HY-N0787 |
Cryptochlorogenic acid |
|
99.87% |
Unkown |
| HY-N0457 |
Chicoric acid |
Inducer |
99.82% |
Unkown |
| HY-151527 |
PI3K/Akt/CREB activator 1 |
|
98.64% |
Unkown |
| HY-N1435 |
Oroxin B |
|
99.39% |
Unkown |
| HY-15719 |
NU 7026 |
|
99.97% |
Unkown |
| HY-N0361 |
Dihydrocapsaicin |
|
99.93% |
Unkown |
| HY-12030 |
PIK-90 |
Inhibitor |
99.70% |
Unkown |
| HY-N2515 |
Ginsenoside Rk1 |
|
99.90% |
Unkown |
| HY-N0031 |
Plantamajoside |
|
99.80% |
Unkown |
| HY-106591A |
4-Vinylcyclohexene dioxide |
|
98.57% |
Unkown |
| HY-13532 |
AS-252424 |
Inhibitor |
99.66% |
Unkown |
| HY-13425 |
Deguelin |
|
99.20% |
Unkown |
| HY-N0284 |
Esculetin |
Inhibitor |
99.79% |
Unkown |
| HY-103450 |
G36 |
Antagonist |
99.35% |
Unkown |
| HY-P1410C |
D-GsMTx4 TFA |
Inhibitor |
99.89% |
Unkown |
| HY-N0330 |
Momordin Ic |
|
99.78% |
Unkown |
| HY-113308 |
Taurolithocholic acid |
|
99.7% |
Unkown |
| HY-116035 |
Nimbolide |
|
99.79% |
Unkown |
| HY-W011927 |
4,4'-Sulfonyldiphenol |
|
99.81% |
Unkown |
| HY-12046 |
PIK-93 |
Inhibitor |
99.81% |
Unkown |
| HY-N0076 |
Bilobalide |
Inhibitor |
99.92% |
Unkown |
| HY-10114 |
TGX-221 |
Inhibitor |
99.59% |
Unkown |
| HY-N0815 |
Resibufogenin |
|
99.93% |
Unkown |
| HY-N0563 |
Alizarin |
|
99.48% |
Unkown |
| HY-P1925A |
GO-203 TFA |
|
98.39% |
Unkown |
| HY-131615 |
TPC2-A1-P |
Agonist |
99.79% |
Unkown |
| HY-124760 |
hSMG-1 inhibitor 11e |
Inhibitor |
99.94% |
Unkown |
| HY-N1381 |
Periplocin |
Inducer |
99.81% |
Unkown |
| HY-N0448 |
10-Gingerol |
|
99.48% |
Unkown |
| HY-18676 |
OSU-T315 |
|
99.88% |
Unkown |
| HY-15477 |
YS-49 |
|
99.98% |
Unkown |
| HY-12794 |
Vps34-PIK-III |
Inhibitor |
99.63% |
Unkown |
| HY-I1124 |
L-Valine-d8 |
|
99.91% |
Unkown |
| HY-N0847 |
Micheliolide |
Inhibitor |
99.77% |
Unkown |
| HY-N0837 |
Veratramine |
|
99.84% |
Unkown |
| HY-N6739 |
Beauvericin |
|
99.97% |
Unkown |
| HY-N0103 |
Sophocarpine |
|
99.85% |
Unkown |
| HY-N1346 |
Robinin |
|
99.96% |
Unkown |
| HY-18939 |
N6-Cyclohexyladenosine |
|
99.98% |
Unkown |
| HY-N2187 |
Deoxyshikonin |
|
99.96% |
Unkown |
| HY-N0876 |
Arenobufagin |
Inducer |
99.82% |
Unkown |
| HY-128483 |
Fusaric acid |
|
99.94% |
Unkown |
| HY-12068 |
PI3K-IN-1 |
Inhibitor |
99.93% |
Unkown |
| HY-150795 |
SY-LB-35 |
|
99.54% |
Unkown |
| HY-N0265 |
Asperosaponin VI |
Inhibitor |
99.62% |
Unkown |
| HY-W010201 |
Citronellol |
|
98.40% |
Unkown |
| HY-103100 |
SB-699551 |
|
99.53% |
Unkown |
| HY-130413 |
Protectin D1 |
|
99.10% |
Unkown |
| HY-131015 |
HaXS8 |
|
99.28% |
Unkown |
| HY-160093 |
SQLE-IN-1 |
|
99.21% |
Unkown |
| HY-N0717S6 |
L-Valine-13C5 |
|
99.6% |
Unkown |
| HY-N0819 |
Raddeanin A |
|
98.55% |
Unkown |
| HY-N2593 |
Isorhapontigenin |
|
99.82% |
Unkown |
| HY-118119 |
CAY10526 |
|
99.12% |
Unkown |
| HY-N0493 |
Pectolinarigenin |
|
99.98% |
Unkown |
| HY-N1255 |
Scoulerine |
|
99.99% |
Unkown |
| HY-N7204 |
4-Hydroxyderricin |
|
99.79% |
Unkown |
| HY-128574 |
D927 |
Activator |
99.46% |
Unkown |
| HY-143404 |
PI3K-IN-30 |
Inhibitor |
98.19% |
Unkown |
| HY-10109 |
AS-605240 |
|
99.36% |
Unkown |
| HY-15290 |
AIM-100 |
Inhibitor |
99.95% |
Unkown |
| HY-162713 |
MTX-531 |
|
99.87% |
Unkown |
| HY-10044 |
WYE-132 |
|
99.90% |
Unkown |
| HY-110171A |
iMDK quarterhydrate |
Inhibitor |
99.37% |
Unkown |
| HY-N0078 |
Ginkgolic Acid (C13:0) |
Inhibitor |
99.92% |
Unkown |
| HY-N2037A |
Higenamine hydrochloride |
|
99.34% |
Unkown |
| HY-N2484 |
Methylnissolin |
Inhibitor |
99.92% |
Unkown |
| HY-125848 |
Ginsenoside F2 |
|
99.92% |
Unkown |
| HY-12763 |
GNE-317 |
Inhibitor |
98.76% |
Unkown |
| HY-156406 |
PITCOIN4 |
Inhibitor |
99.97% |
Unkown |
| HY-122862 |
RAS inhibitor Abd-7 |
Inhibitor |
99.57% |
Unkown |
| HY-N0616 |
Trifolirhizin |
|
98.37% |
Unkown |
| HY-N0721 |
Neoandrographolide |
|
99.41% |
Unkown |
| HY-N1535 |
Ponicidin |
Inducer |
99.93% |
Unkown |
| HY-P4322 |
H-Ile-Lys-Val-Ala-Val-OH |
Activator |
99.35% |
Unkown |
| HY-10683 |
PKI-402 |
Inhibitor |
99.17% |
Unkown |
| HY-117163 |
FzM1.8 |
Agonist |
98.93% |
Unkown |
| HY-100398 |
PF-04979064 |
Inhibitor |
99.93% |
Unkown |
| HY-10115A |
PI-103 Hydrochloride |
|
98.06% |
Unkown |
| HY-128741 |
D-Allose |
|
99.85% |
Unkown |
| HY-N0885 |
Telocinobufagin |
|
99.93% |
Unkown |
| HY-N2112 |
Glaucocalyxin A |
|
99.88% |
Unkown |
| HY-N2447 |
Amarogentin |
|
99.93% |
Unkown |
| HY-N5112B |
β,β-Dimethylacrylshikonin |
|
99.30% |
Unkown |
| HY-N6950 |
Hederacolchiside A1 |
|
98.28% |
Unkown |
| HY-113402A |
Gamma-glutamylcysteine TFA |
|
96.68% |
Unkown |
| HY-139534 |
ARI-1 |
|
99.16% |
Unkown |
| HY-N0657 |
Pinoresinol Diglucoside |
|
99.84% |
Unkown |
| HY-N0712 |
Typhaneoside |
|
99.74% |
Unkown |
| HY-13431 |
KU-0060648 |
Inhibitor |
99.87% |
Unkown |
| HY-160099 |
20-5,14-HEDE |
|
98.34% |
Unkown |
| HY-N0314 |
Pectolinarin |
|
99.89% |
Unkown |
| HY-N0735 |
Phellodendrine chloride |
|
99.68% |
Unkown |
| HY-N2110 |
Phellopterin |
|
99.94% |
Unkown |
| HY-N2491 |
Deoxyelephantopin |
Inhibitor |
99.87% |
Unkown |
| HY-N2554 |
Osthenol |
|
99.15% |
Unkown |
| HY-N5027 |
Oxyberberine |
|
99.78% |
Unkown |
| HY-N6263 |
EGCG Octaacetate |
Inhibitor |
98.57% |
Unkown |
| HY-10110 |
IC-87114 |
Inhibitor |
99.85% |
Unkown |
| HY-106012 |
PI4K-IN-1 |
Inhibitor |
98.59% |
Unkown |
| HY-146751 |
PI3K/Akt/mTOR-IN-2 |
|
99.93% |
Unkown |
| HY-N0660 |
Jujuboside B |
|
99.92% |
Unkown |
| HY-N0728S3 |
α-Linolenic acid-13C18 |
Inhibitor |
99.5% |
Unkown |
| HY-Y1322 |
Triphenyl phosphate |
|
99.67% |
Unkown |
| HY-135827 |
Roginolisib |
Inhibitor |
99.66% |
Unkown |
| HY-N0777 |
Isorhamnetin-3-O-glucoside |
|
99.96% |
Unkown |
| HY-N0747 |
Oxypeucedanin |
|
99.50% |
Unkown |
| HY-N3312 |
Matairesinol |
Inhibitor |
98.78% |
Unkown |
| HY-N0696 |
Sipeimine |
Inhibitor |
98.57% |
Unkown |
| HY-N0910 |
Notoginsenoside Ft1 |
|
99.49% |
Unkown |
| HY-11002 |
CP-466722 |
Inhibitor |
99.74% |
Unkown |
| HY-111570 |
PI3Kγ inhibitor AZ2 |
Inhibitor |
99.25% |
Unkown |
| HY-N1431 |
Tabersonine |
|
98.13% |
Unkown |
| HY-N4205 |
Tetrahydropiperine |
Inhibitor |
99.41% |
Unkown |
| HY-10811 |
GNE-493 |
Inhibitor |
99.81% |
Unkown |
| HY-101146 |
SF2523 |
Inhibitor |
99.34% |
Unkown |
| HY-13440 |
AMG 511 |
Inhibitor |
99.76% |
Unkown |
| HY-141807 |
MS21 |
|
99.64% |
Unkown |
| HY-D0892 |
NSP-DMAE-NHS |
|
99.48% |
Unkown |
| HY-N0534 |
Vitexin-2"-O-rhamnoside |
|
99.78% |
Unkown |
| HY-N2081 |
Skimmianine |
Inhibitor |
99.90% |
Unkown |
| HY-N2132 |
Flavokawain B |
|
99.99% |
Unkown |
| HY-N3354 |
Lupiwighteone |
Inducer |
98.92% |
Unkown |
| HY-N5048 |
Galloylpaeoniflorin |
Inhibitor |
98.30% |
Unkown |
| HY-N6002 |
3'-Hydroxypterostilbene |
Inducer |
99.89% |
Unkown |
| HY-W011927S |
4,4'-Sulfonyldiphenol-d8 |
|
99.21% |
Unkown |
| HY-112440 |
HZX-02-059 |
Inhibitor |
99.40% |
Unkown |
| HY-115620 |
AQX-016A |
|
99.51% |
Unkown |
| HY-156371 |
MIPS-21335 |
Inhibitor |
99.61% |
Unkown |
| HY-B1885 |
Fenitrothion |
|
99.43% |
Unkown |
| HY-N0392 |
Polygalasaponin F |
|
99.85% |
Unkown |
| HY-N0479 |
Licarin B |
Activator |
99.93% |
Unkown |
| HY-N0695 |
Schisantherin B |
|
99.75% |
Unkown |
| HY-N0717S |
L-Valine-15N |
|
99.74% |
Unkown |
| HY-N0726 |
Dracorhodin perchlorate |
|
99.02% |
Unkown |
| HY-N6983 |
Licoricesaponin G2 |
|
99.87% |
Unkown |
| HY-B0633D |
Hyaluronic acid sodium (MW 200-1560) |
|
99.41% |
Unkown |
| HY-101667 |
LTURM34 |
Inhibitor |
99.35% |
Unkown |
| HY-173405 |
VVD-699 |
Inhibitor |
99.83% |
Unkown |
| HY-131972 |
PF-06843195 |
Inhibitor |
98.12% |
Unkown |
| HY-15672 |
FM19G11 |
Inhibitor |
98.39% |
Unkown |
| HY-11095 |
NPS 2390 |
|
99.90% |
Unkown |
| HY-117548 |
UNC1062 |
|
98.92% |
Unkown |
| HY-14971 |
(E)-Akt inhibitor-IV |
Inhibitor |
98.63% |
Unkown |
| HY-19763 |
Ifupinostat |
|
99.30% |
Unkown |
| HY-40029 |
(S)-1-Boc-3-aminopiperidine |
|
99.95% |
Unkown |
| HY-N0699 |
Daphnoretin |
|
99.83% |
Unkown |
| HY-N0717S1 |
L-Valine-13C5,15N |
|
99.64% |
Unkown |
| HY-N0728R |
α-Linolenic acid (Standard) |
Inhibitor |
99.32% |
Unkown |
| HY-N3127 |
Orobol |
Inhibitor |
99.74% |
Unkown |
| HY-N3651 |
Curzerenone |
|
98.55% |
Unkown |
| HY-N5072 |
Desmethylglycitein |
Inhibitor |
99.99% |
Unkown |
| HY-N1103 |
Vasicine |
|
98.80% |
Unkown |
| HY-101272 |
GDC-0326 |
Inhibitor |
99.92% |
Unkown |
| HY-107365 |
PQR530 |
Inhibitor |
99.98% |
Unkown |
| HY-17044A |
Duvelisib (R enantiomer) |
Inhibitor |
99.00% |
Unkown |
| HY-19798 |
PI4KIIIbeta-IN-9 |
Inhibitor |
99.18% |
Unkown |
| HY-112443 |
AZD3458 |
Inhibitor |
99.71% |
Unkown |
| HY-12034 |
WYE-354 |
|
98.03% |
Unkown |
| HY-111508 |
PI3K/mTOR Inhibitor-2 |
Inhibitor |
99.10% |
Unkown |
| HY-106263B |
Tyroserleutide hydrochloride |
|
99.92% |
Unkown |
| HY-108016 |
Peruvoside |
|
99.32% |
Unkown |
| HY-118020A |
Loliolide |
|
99.92% |
Unkown |
| HY-128393 |
Trilinolein |
|
98.0% |
Unkown |
| HY-B0633I |
Hyaluronic acid sodium (MW 800kDa) |
|
/ |
Unkown |
| HY-N0430A |
Coptisine Sulfate |
|
99.37% |
Unkown |
| HY-100470 |
NSC781406 |
Inhibitor |
99.97% |
Unkown |
| HY-112897 |
IITZ-01 |
|
98.18% |
Unkown |
| HY-100385 |
Brevianamide F |
Inhibitor |
99.03% |
Unkown |
| HY-100603 |
GSK-F1 |
Inhibitor |
95.06% |
Unkown |
| HY-13531 |
AS-604850 |
Inhibitor |
99.32% |
Unkown |
| HY-149669 |
PH14 |
Inhibitor |
99.29% |
Unkown |
| HY-15294 |
CZC24832 |
Inhibitor |
99.07% |
Unkown |
| HY-161615 |
PROTAC ATR degrader-2 |
|
99.73% |
Unkown |
| HY-16596 |
CNX-1351 |
Inhibitor |
98.87% |
Unkown |
| HY-N0670 |
Tenacissoside H |
Inhibitor |
99.89% |
Unkown |
| HY-N2787 |
8-Prenylnaringenin |
|
99.63% |
Unkown |
| HY-N6064 |
Polygalacin D |
|
99.95% |
Unkown |
| HY-11042 |
GNE-477 |
Inhibitor |
98.75% |
Unkown |
| HY-107364 |
MTX-211 |
Inhibitor |
99.81% |
Unkown |
| HY-18085S1 |
Quercetin-d3 |
|
98.73% |
Unkown |
| HY-108606 |
PI-828 |
Inhibitor |
99.62% |
Unkown |
| HY-118712 |
WYE-23 |
Inhibitor |
99.24% |
Unkown |
| HY-126066 |
(-)-Syringaresinol |
|
99.93% |
Unkown |
| HY-165099 |
C-8 Ceramide-1-phosphate |
|
99.0% |
Unkown |
| HY-17587 |
4-Methylbenzylidene camphor |
|
99.87% |
Unkown |
| HY-G0007 |
Omeprazole sulfone |
Control |
99.23% |
Unkown |
| HY-N0103A |
Sophocarpine monohydrate |
|
99.91% |
Unkown |
| HY-N1967 |
Dihydrocurcumin |
Modulator |
99.58% |
Unkown |
| HY-W009141 |
1-Monopalmitin |
|
99.89% |
Unkown |
| HY-W130965 |
1-Formyl-beta-carboline |
Inhibitor |
99.70% |
Unkown |
| HY-15643A |
LY 303511 hydrochloride |
|
98.87% |
Unkown |
| HY-103224 |
PIT-1 |
Inhibitor |
98.08% |
Unkown |
| HY-112613 |
UCB9608 |
Inhibitor |
99.59% |
Unkown |
| HY-136198 |
SRX3207 |
Inhibitor |
98.50% |
Unkown |
| HY-121222 |
alpha-Bisabolol |
|
80.0% |
Unkown |
| HY-124652 |
TBK1/IKKε-IN-4 |
Inhibitor |
99.42% |
Unkown |
| HY-128333 |
PI3K/mTOR Inhibitor-4 |
Inhibitor |
97.04% |
Unkown |
| HY-149091 |
KDM5B-IN-4 |
Inhibitor |
99.68% |
Unkown |
| HY-150618 |
PI3Kα-IN-9 |
|
98.78% |
Unkown |
| HY-153894 |
SRX3177 |
|
99.33% |
Unkown |
| HY-156681A |
(S)-Tersolisib |
Control |
99.18% |
Unkown |
| HY-174976 |
FHND5032 |
Inhibitor |
99.49% |
Unkown |
| HY-N0717S4 |
L-Valine-1-13C |
|
99.75% |
Unkown |
| HY-N1103A |
Vasicine hydrochloride |
|
98.62% |
Unkown |
| HY-N2445 |
Flavokawain C |
|
99.79% |
Unkown |
| HY-N3000 |
6-Methoxydihydrosanguinarine |
|
99.88% |
Unkown |
| HY-P2196A |
ELA-32(human) TFA |
Agonist |
99.93% |
Unkown |
| HY-167876 |
PQR514 |
|
99.28% |
Unkown |
| HY-151622 |
PI3K/mTOR Inhibitor-11 |
Inhibitor |
99.65% |
Unkown |
| HY-143275 |
HL-8 |
Inhibitor |
99.17% |
Unkown |
| HY-145526 |
Hydroxy celecoxib |
Activator |
98.71% |
Unkown |
| HY-14971A |
AKT inhibitor IV |
Inhibitor |
99.40% |
Unkown |
| HY-157169 |
IBL-302 |
Inhibitor |
98.21% |
Unkown |
| HY-162382 |
KTC1101 |
Inhibitor |
98.09% |
Unkown |
| HY-172741 |
Dioctanoyl PI(3,5)P2 sodium |
|
98.7% |
Unkown |
| HY-60298 |
6-Bromo-1H-indazole |
|
99.40% |
Unkown |
| HY-N3011 |
Iridin |
|
99.72% |
Unkown |
| HY-N6017 |
Bakkenolide A |
|
99.99% |
Unkown |
| HY-W004121 |
4-Biphenylsulfonyl chloride |
|
99.59% |
Unkown |
| HY-W1126235 |
DS02312223 |
Activator |
98.24% |
Unkown |
| HY-Y1177 |
Diphenyl disulfide |
|
99.96% |
Unkown |
| HY-12235 |
PI-3065 |
Inhibitor |
98.97% |
Unkown |
| HY-15477A |
YS-49 monohydrate |
|
99.56% |
Unkown |
| HY-120213 |
YH-306 |
|
98.34% |
Unkown |
| HY-125847 |
Salvianolic acid F |
|
99.50% |
Unkown |
| HY-143403 |
PI3K-IN-31 |
Inhibitor |
99.33% |
Unkown |
| HY-168608 |
TRPM7-IN-1 |
|
98.83% |
Unkown |
| HY-17508S1 |
Clarithromycin-d3 |
Inhibitor |
99.90% |
Unkown |
| HY-178500A |
WCY-8-67 TFA |
|
99.40% |
Unkown |
| HY-181420A |
BBO-11818 |
|
/ |
Unkown |
| HY-46866 |
Isoegomaketone |
|
95.04% |
Unkown |
| HY-N2045 |
Musk ketone |
|
99.21% |
Unkown |
| HY-N4246 |
Bacopaside I |
|
99.20% |
Unkown |
| HY-113402R |
Gamma-glutamylcysteine (Standard) |
|
98.14% |
Unkown |
| HY-118717 |
mTOR inhibitor WYE-28 |
Inhibitor |
99.75% |
Unkown |
| HY-15868 |
HS-173 |
|
99.04% |
Unkown |
| HY-136268 |
AQX-435 |
Activator |
99.15% |
Unkown |
| HY-110193 |
SPP-86 |
Inhibitor |
99.87% |
Unkown |
| HY-123952 |
RTC-5 |
Inhibitor |
99.37% |
Unkown |
| HY-12895 |
SKI V |
|
98.95% |
Unkown |
| HY-13333 |
NVP-BAG956 |
Inhibitor |
99.21% |
Unkown |
| HY-13514 |
TG 100713 |
Inhibitor |
99.21% |
Unkown |
| HY-174461 |
PROTAC PI3Kα degrader-1 |
Degrader |
99.21% |
Unkown |
| HY-176811 |
VVD-442 |
Inhibitor |
99.97% |
Unkown |
| HY-19312S |
3-Methyladenine-d3 |
|
98.98% |
Unkown |
| HY-19341 |
Compound 401 |
Inhibitor |
99.97% |
Unkown |
| HY-N0728A |
α-Linolenic acid sodium |
Inhibitor |
96.67% |
Unkown |
| HY-N0761A |
trans-Isoferulic acid |
|
99.93% |
Unkown |
| HY-N0857 |
Deoxyandrographolide |
Activator |
98.0% |
Unkown |
| HY-N1399 |
Androsin |
|
99.94% |
Unkown |
| HY-N2590 |
Lupenone |
Inhibitor |
99.74% |
Unkown |
| HY-N3720 |
Demethoxycapillarisin |
Inhibitor |
98.0% |
Unkown |
| HY-N6932 |
Voacamine |
|
99.64% |
Unkown |
| HY-N7363 |
Isolongifolene |
Inducer |
98.0% |
Unkown |
| HY-NP203 |
High density lipoprotein (human) |
Activator |
98.00% |
Unkown |
| HY-W127575 |
Cholesta-3,5-diene |
Activator |
99.54% |
Unkown |
| HY-10681R |
Gedatolisib (Standard) |
Inhibitor |
97.70% |
Unkown |
| HY-126049 |
(S)-Oxiracetam |
Inhibitor |
99.56% |
Unkown |
| HY-130687A |
Psicose |
Activator |
99.90% |
Unkown |
| HY-20176 |
2,4-Dichlorothieno[3,2-d]pyrimidine |
|
/ |
Unkown |
| HY-10812 |
GNE-490 |
Inhibitor |
96.79% |
Unkown |
| HY-18650 |
KU 59403 |
Inhibitor |
99.23% |
Unkown |
| HY-111383 |
LX2343 |
|
99.80% |
Unkown |
| HY-111510 |
IPI-3063 |
Inhibitor |
99.59% |
Unkown |
| HY-112608 |
CHMFL-PI3KD-317 |
Inhibitor |
98.04% |
Unkown |
| HY-132231 |
FD223 |
|
98.05% |
Unkown |
| HY-13530 |
CAY10505 |
|
99.75% |
Unkown |
| HY-107207 |
Kaempferol 3-neohesperidoside |
|
99.68% |
Unkown |
| HY-12652 |
AZD3147 |
Inhibitor |
99.93% |
Unkown |
| HY-131502 |
Taspine |
Inhibitor |
98.0% |
Unkown |
| HY-133907 |
NVS-PI3-4 |
Inhibitor |
99.40% |
Unkown |
| HY-144993 |
PI3Kδ/γ-IN-1 |
Inhibitor |
99.39% |
Unkown |
| HY-15271 |
WYE-687 |
Inhibitor |
98.05% |
Unkown |
| HY-163299 |
pan-KRAS-IN-5 |
|
96.70% |
Unkown |
| HY-163853 |
Antidiabetic agent 6 |
Activator |
99.97% |
Unkown |
| HY-169212 |
I194496 |
Inhibitor |
98.52% |
Unkown |
| HY-17635S |
Leniolisib-d5 |
Inhibitor |
98.78% |
Unkown |
| HY-176812 |
VVD-849 |
|
99.76% |
Unkown |
| HY-N0143A |
Phlorizin dihydrate |
|
99.51% |
Unkown |
| HY-N2000 |
Bellidifolin |
Modulator |
99.74% |
Unkown |
| HY-N2911 |
Auriculasin |
|
98.58% |
Unkown |
| HY-N3035 |
Tetrahydroepiberberine |
Inhibitor |
99.38% |
Unkown |
| HY-N5136 |
25(R,S)-Ruscogenin |
Inhibitor |
99.83% |
Unkown |
| HY-N6841 |
Rhodiolin |
|
98% |
Unkown |
| HY-N6896 |
Isoviolanthin |
Inhibitor |
99.87% |
Unkown |
| HY-W005308 |
N-BOC-DL-serine methyl ester |
|
98.0% |
Unkown |
| HY-120265 |
MIPS-9922 |
Inhibitor |
99.25% |
Unkown |
| HY-12340 |
ETP-46321 |
Inhibitor |
99.34% |
Unkown |
| HY-N0728S |
α-Linolenic acid-d5 |
Inhibitor |
99.9% |
Unkown |
| HY-101776A |
Desmethyl-VS-5584 hydrochloride |
Inhibitor |
98.63% |
Unkown |
| HY-11105 |
Pilaralisib analogue |
|
99.74% |
Unkown |
| HY-146223 |
AZD4625 |
|
98.44% |
Unkown |
| HY-101921 |
PI3Kδ-IN-1 |
Inhibitor |
99.60% |
Unkown |
| HY-131345 |
PI3Kα-IN-4 |
Inhibitor |
99.76% |
Unkown |
| HY-131345A |
(S)-PI3Kα-IN-4 |
Inhibitor |
99.77% |
Unkown |
| HY-147419 |
Vulolisib |
Inhibitor |
99.61% |
Unkown |
| HY-B0965AS |
Thioridazine-d3 hydrochloride |
|
98.25% |
Unkown |
| HY-100603A |
(S)-GSK-F1 |
Inhibitor |
98.01% |
Unkown |
| HY-10620 |
PI3K-IN-22 |
Inhibitor |
99.50% |
Unkown |
| HY-110109 |
ETP-45658 |
Inhibitor |
98.97% |
Unkown |
| HY-118521 |
AS-041164 |
Inhibitor |
99.02% |
Unkown |
| HY-124535 |
TGX-115 |
Inhibitor |
99.31% |
Unkown |
| HY-124834 |
Nrf2 activator-10 |
|
98.65% |
Unkown |
| HY-130307 |
Rubrofusarin |
Inhibitor |
98.19% |
Unkown |
| HY-137340 |
WH-10417-099 |
Degrader |
98.14% |
Unkown |
| HY-147284 |
PI3K-IN-37 |
Inhibitor |
99.0% |
Unkown |
| HY-150019 |
PI3K-IN-36 |
Inhibitor |
98.76% |
Unkown |
| HY-153120A |
PI3K/mTOR Inhibitor-13 sodium |
Inhibitor |
98.11% |
Unkown |
| HY-155066 |
FD274 |
|
99.45% |
Unkown |
| HY-157704 |
18:1 PI(3)P |
|
99% |
Unkown |
| HY-161366 |
OMS14 |
Inhibitor |
99.09% |
Unkown |
| HY-168906 |
BI-113823 |
|
99.23% |
Unkown |
| HY-18085S |
Quercetin-d5 |
|
96.72% |
Unkown |
| HY-B0633E |
Hyaluronic acid, low endotoxin |
|
/ |
Unkown |
| HY-N0427 |
Phellodendrine |
|
99.60% |
Unkown |
| HY-N12044 |
Asparanin A |
Inducer |
/ |
Unkown |
| HY-N1904 |
4′-Hydroxywogonin |
|
98.22% |
Unkown |
| HY-N4042 |
Hirsutenone |
Inhibitor |
99.74% |
Unkown |
| HY-N7635 |
Oleanolic acid 28-O-β-D-glucopyranoside |
|
99.42% |
Unkown |
| HY-N8884 |
Coelonin |
Inhibitor |
98.0% |
Unkown |
| HY-P6292 |
KS-133 |
|
98.75% |
Unkown |
| HY-W049881 |
9-Methyl-β-carboline |
|
99.86% |
Unkown |
| HY-W713284 |
2-Ethylhexyl (E)-3-(4-(methoxy-d3)phenyl)acrylate |
|
99.87% |
Unkown |
| HY-122949 |
Momordicine I |
|
97.0% |
Unkown |
| HY-12338 |
ON 146040 |
Inhibitor |
95.05% |
Unkown |
| HY-155520 |
Antileishmanial agent-19 |
Inhibitor |
99.45% |
Unkown |
| HY-50673A |
Dactolisib hydrochloride |
|
99.41% |
Unkown |
| HY-N6739S |
Beauvericin-13C45 |
Inhibitor |
≥99% |
Unkown |
| HY-101517 |
PI3K-IN-2 |
Inhibitor |
99.62% |
Unkown |
| HY-12481 |
SAR405 |
Inhibitor |
99.74% |
Unkown |
| HY-178500 |
WCY-8-67 |
|
/ |
Unkown |
| HY-131910 |
IHMT-PI3Kδ-372 |
Inhibitor |
99.69% |
Unkown |
| HY-133124 |
PARP/PI3K-IN-1 |
|
99.40% |
Unkown |
| HY-101517A |
(S)-PI3K-IN-2 |
Inhibitor |
99.50% |
Unkown |
| HY-103030 |
PI3K-IN-32 |
Inhibitor |
99.7% |
Unkown |
| HY-10681S |
Gedatolisib-d8 |
|
/ |
Unkown |
| HY-108418A |
(R)-PI3Kδ-IN-15 |
Control |
99.52% |
Unkown |
| HY-109633 |
PI3K/mTOR-IN-23 |
Inhibitor |
99.0% |
Unkown |
| HY-109633A |
PI3K/mTOR-IN-23 dihydrochloride |
Inhibitor |
99.70% |
Unkown |
| HY-111209 |
Pichromene |
Inhibitor |
98.7% |
Unkown |
| HY-112172 |
Tenalisib R Enantiomer |
|
99.63% |
Unkown |
| HY-113308S1 |
Taurolithocholic acid-d4 |
|
98.36% |
Unkown |
| HY-120438 |
TASP0415914 |
Inhibitor |
99.02% |
Unkown |
| HY-123849 |
SN32976 |
Inhibitor |
99.49% |
Unkown |
| HY-125542 |
DCZ3301 |
|
99.73% |
Unkown |
| HY-132276 |
PtdIns-(3,4,5)-P3-biotin sodium |
|
98.0% |
Unkown |
| HY-13504 |
PIK-293 |
Inhibitor |
99.41% |
Unkown |
| HY-136512 |
Streptazolin |
|
98.65% |
Unkown |
| HY-13864 |
PF-4989216 |
|
99.38% |
Unkown |
| HY-147768 |
PI3K/AKT-IN-2 |
|
98.10% |
Unkown |
| HY-15271A |
WYE-687 dihydrochloride |
Inhibitor |
≥98.0% |
Unkown |
| HY-153306A |
(S)-Zovegalisib |
Control |
99.89% |
Unkown |
| HY-155232 |
PI3Kδ-IN-16 |
|
99.02% |
Unkown |
| HY-16122B |
CAL-130 Hydrochloride |
Inhibitor |
98.74% |
Unkown |
| HY-174798 |
PI3Kα Ligand-1 |
Ligand |
98.0% |
Unkown |
| HY-18085AS |
Quercetin-d3 hydrate |
|
96.44% |
Unkown |
| HY-203618 |
PI3K/mTOR ligand-1 |
Ligand |
97.28% |
Unkown |
| HY-N0430 |
Coptisine |
|
/ |
Unkown |
| HY-N0451R |
Acacetin (Standard) |
Inducer |
98.19% |
Unkown |
| HY-N0728S2 |
α-Linolenic acid-d14 |
Inhibitor |
/ |
Unkown |
| HY-N10144 |
Shinpterocarpin |
Inhibitor |
/ |
Unkown |
| HY-N2051 |
Zeylenone |
Activator |
98.0% |
Unkown |
| HY-N3260 |
Methyllucidone |
|
98.0% |
Unkown |
| HY-N3542 |
Carpachromene |
Inhibitor |
98.84% |
Unkown |
| HY-N6580 |
Ginsenoside Rg4 |
|
99.94% |
Unkown |
| HY-W010201R |
Citronellol (Standard) |
|
97.16% |
Unkown |
| HY-W040417 |
Boc-L-cyclobutylglycine |
|
98.91% |
Unkown |
| HY-108418 |
PI3Kδ-IN-15 |
Inhibitor |
99.52% |
Unkown |
| HY-15174R |
Dactolisib Tosylate (Standard) |
|
98.95% |
Unkown |
| HY-156872 |
MTX-216 |
|
/ |
Unkown |
| HY-15872 |
FTI-277 |
|
/ |
Unkown |
| HY-16355 |
NVP-QAV-572 |
Inhibitor |
98.53% |
Unkown |
| HY-176422 |
(S,R,S)-AHPC-Amide-PEG2-C2-NH2 |
|
97.16% |
Unkown |
| HY-N0265R |
Asperosaponin VI (Standard) |
Inhibitor |
99.46% |
Unkown |
| HY-N2026A |
Propylparaben sodium |
Agonist |
99.03% |
Unkown |
| HY-U00326 |
PI3Kα/mTOR-IN-1 |
Inhibitor |
99.30% |
Unkown |
| HY-101798 |
MDVN1003 |
Inhibitor |
/ |
Unkown |
| HY-142646 |
PI3Kδ-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-144876 |
RIDR-PI-103 |
Inducer |
98.02% |
Unkown |
| HY-18085S2 |
Quercetin-13C3 |
|
/ |
Unkown |
| HY-101114 |
LAS191954 |
Inhibitor |
/ |
Unkown |
| HY-112602 |
PI3K/mTOR Inhibitor-1 |
Inhibitor |
/ |
Unkown |
| HY-113308AS |
Taurolithocholic acid-d4 sodium |
|
99.4% |
Unkown |
| HY-128582 |
PI3K/HDAC-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-132880 |
GSK251 |
Inhibitor |
99.88% |
Unkown |
| HY-134472 |
PI3Kδ-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-151137 |
HSP90/mTOR-IN-1 |
|
/ |
Unkown |
| HY-B1203S |
Fludrocortisone-d5 |
|
/ |
Unkown |
| HY-100424 |
PI3K-IN-63 |
Inhibitor |
/ |
Unkown |
| HY-101115 |
PI3K-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-112286 |
PI3Kγ inhibitor 2 |
Inhibitor |
/ |
Unkown |
| HY-112439 |
PI3Kdelta inhibitor 1 |
Inhibitor |
/ |
Unkown |
| HY-112614 |
ATM Inhibitor-1 |
Inhibitor |
/ |
Unkown |
| HY-132299 |
PI3Kγ inhibitor 4 |
Inhibitor |
/ |
Unkown |
| HY-132807 |
Amdizalisib |
Inhibitor |
/ |
Unkown |
| HY-133029 |
PI3K-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-162878 |
CHF-6523 |
Inhibitor |
/ |
Unkown |
| HY-174366 |
JMC14 |
Inhibitor |
/ |
Unkown |
| HY-10109A |
AS-605240 potassium |
Inhibitor |
/ |
Unkown |
| HY-101145 |
CK37 |
Inhibitor |
/ |
Unkown |
| HY-10116 |
PI-540 |
Inhibitor |
/ |
Unkown |
| HY-101776 |
Desmethyl-VS-5584 |
Inhibitor |
/ |
Unkown |
| HY-105666 |
TGX-155 |
Inhibitor |
/ |
Unkown |
| HY-106006 |
RV-1729 |
Inhibitor |
/ |
Unkown |
| HY-107387 |
PF-376304 |
Inhibitor |
/ |
Unkown |
| HY-108958 |
(Rac)-AZD8186 |
Inhibitor |
/ |
Unkown |
| HY-108959 |
D-87503 |
Inhibitor |
/ |
Unkown |
| HY-109198A |
Zandelisib hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-111058 |
D-106669 |
Inhibitor |
/ |
Unkown |
| HY-111137 |
Puquitinib |
Inhibitor |
/ |
Unkown |
| HY-111172 |
Inotilone |
Inhibitor |
/ |
Unkown |
| HY-112191 |
PI3K-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-113308AS2 |
Taurolithocholic acid-d4-1 sodium |
|
/ |
Unkown |
| HY-113308S |
Taurolithocholic acid-d5 |
|
/ |
Unkown |
| HY-113572 |
PX-866-17OH |
Inhibitor |
/ |
Unkown |
| HY-113817 |
SHIP1 activator 1 |
|
/ |
Unkown |
| HY-114923 |
SU-11752 |
Inhibitor |
/ |
Unkown |
| HY-115814 |
AM-1430 |
Inhibitor |
/ |
Unkown |
| HY-116431 |
I-BOP |
Agonist |
/ |
Unkown |
| HY-116497 |
PH11 |
Inhibitor |
/ |
Unkown |
| HY-116604 |
RLX |
Inhibitor |
/ |
Unkown |
| HY-116604A |
RLX hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-120116 |
AM-8508 |
Inhibitor |
/ |
Unkown |
| HY-120135 |
LTURM 36 |
Inhibitor |
/ |
Unkown |
| HY-120281 |
ST-168 |
|
/ |
Unkown |
| HY-121012 |
(rac)-AG-205 |
|
/ |
Unkown |
| HY-12279F |
Umbralisib R-enantiomer |
Inhibitor |
99.52% |
Unkown |
| HY-123862 |
LAS195319 |
Inhibitor |
/ |
Unkown |
| HY-124615 |
ST-162 |
Antagonist |
/ |
Unkown |
| HY-124647 |
PI3Kα-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-12482 |
X-370 |
|
/ |
Unkown |
| HY-125376 |
PI3Kδ-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-126083 |
17β-Hydroxywortmannin |
Inhibitor |
/ |
Unkown |
| HY-128027 |
eCF309 |
Inhibitor |
98.2% |
Unkown |
| HY-128393S2 |
Trilinolein-d5 |
|
/ |
Unkown |
| HY-128633 |
DHW-208 |
|
/ |
Unkown |
| HY-128634 |
Anticancer agent 164 |
|
/ |
Unkown |
| HY-128741S |
D-Allose-13C |
|
/ |
Unkown |
| HY-128741S1 |
D-Allose-13C-1 |
|
/ |
Unkown |
| HY-128741S2 |
D-Allose-13C-2 |
|
/ |
Unkown |
| HY-130133 |
DHW-221 |
|
/ |
Unkown |
| HY-131055 |
Mytoxin B |
|
/ |
Unkown |
| HY-131910A |
(R)-IHMT-PI3Kδ-372 |
Inhibitor |
99.75% |
Unkown |
| HY-132898 |
PI3K-IN-23 |
Activator |
/ |
Unkown |
| HY-135526 |
Demethoxyviridiol |
Inhibitor |
/ |
Unkown |
| HY-136806 |
PI3K-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-13685S1 |
Miltefosine-d4 |
Inhibitor |
/ |
Unkown |
| HY-138302 |
PF-06862309 |
|
/ |
Unkown |
| HY-139832 |
MCX 28 |
Inhibitor |
/ |
Unkown |
| HY-139880 |
PI3Kγ inhibitor 5 |
Inhibitor |
/ |
Unkown |
| HY-141476 |
PI3K/mTOR Inhibitor-3 |
Inhibitor |
/ |
Unkown |
| HY-14153S |
Tegaserod-d11 |
|
/ |
Unkown |
| HY-141690A |
PI3K-IN-19 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-142676 |
PI3K-IN-26 |
Inhibitor |
/ |
Unkown |
| HY-142677 |
PI3K-IN-27 |
|
/ |
Unkown |
| HY-143472 |
PI3Kδ-IN-11 |
|
/ |
Unkown |
| HY-144059 |
AKT-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-144060 |
AKT-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-144224S |
Tianeptine-d6 hydrochloride |
|
/ |
Unkown |
| HY-144254 |
PI3Kδ-IN-10 |
|
/ |
Unkown |
| HY-144295 |
PI3Kα-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-144450 |
PI3K-IN-29 |
Inhibitor |
/ |
Unkown |
| HY-144686 |
ATM Inhibitor-3 |
Inhibitor |
/ |
Unkown |
| HY-144687 |
ATM Inhibitor-4 |
Inhibitor |
/ |
Unkown |
| HY-144692 |
MEK/PI3K-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-144693 |
MEK/PI3K-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-145338 |
PI3Kβ-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-145358 |
FAP-PI3KI1 |
Inhibitor |
/ |
Unkown |
| HY-145432 |
PI3K-IN-28 |
Inhibitor |
/ |
Unkown |
| HY-146016 |
PI3K/mTOR Inhibitor-5 |
Inhibitor |
/ |
Unkown |
| HY-146159 |
PI3K/HDAC-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-146200 |
PI3K/mTOR Inhibitor-8 |
Inhibitor |
/ |
Unkown |
| HY-146223A |
(3R,10R,14aS)-AZD4625 |
|
98.00% |
Unkown |
| HY-146260 |
NVP-CLR457 |
Inhibitor |
/ |
Unkown |
| HY-146504 |
Topoisomerase I/II inhibitor 3 |
|
/ |
Unkown |
| HY-146743 |
Antitumor agent-53 |
Inducer |
/ |
Unkown |
| HY-146789 |
PI3Kδ/γ-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-146835S |
(Rac)-16:0PI(3,5)P2-d5 ammonium |
|
/ |
Unkown |
| HY-147285 |
PI3K/mTOR Inhibitor-9 |
Inhibitor |
/ |
Unkown |
| HY-147567 |
ATR-IN-15 |
Inhibitor |
/ |
Unkown |
| HY-147613 |
PI3K/mTOR Inhibitor-6 |
Inhibitor |
/ |
Unkown |
| HY-147614 |
PI3K/mTOR Inhibitor-7 |
Inhibitor |
/ |
Unkown |
| HY-147767 |
PI3Kα-IN-6 |
|
/ |
Unkown |
| HY-147792 |
WNY1613 |
Inhibitor |
/ |
Unkown |
| HY-147898 |
PI3K-IN-33 |
|
/ |
Unkown |
| HY-147899 |
PI3K-IN-34 |
|
/ |
Unkown |
| HY-147900 |
PI3K-IN-35 |
|
/ |
Unkown |
| HY-147911 |
COX-2/PI3K-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-147912 |
COX-2/PI3K-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-147913 |
PI3K/Akt/mTOR-IN-3 |
|
/ |
Unkown |
| HY-147966 |
HDAC-IN-43 |
Inhibitor |
/ |
Unkown |
| HY-147983 |
PI3Kα-IN-8 |
|
/ |
Unkown |
| HY-148317 |
PI3Kγ inhibitor 6 |
Inhibitor |
/ |
Unkown |
| HY-148972 |
PI(3,5)P2 diC16 |
|
/ |
Unkown |
| HY-149000 |
PI3Kα-IN-7 |
|
/ |
Unkown |
| HY-149092 |
Anticancer agent 109 |
|
/ |
Unkown |
| HY-149205 |
CXJ-2 |
Inhibitor |
/ |
Unkown |
| HY-149235 |
PI3Kδ-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-149427 |
PI3Kα-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-149472 |
Anti-osteoporosis agent-4 |
Inhibitor |
/ |
Unkown |
| HY-149493 |
IHMT-PI3K-455 |
Inhibitor |
/ |
Unkown |
| HY-149521 |
PI3K-IN-47 |
Inhibitor |
/ |
Unkown |
| HY-149539 |
PLM-101 |
Inhibitor |
/ |
Unkown |
| HY-149556 |
MTX-241F |
Inhibitor |
/ |
Unkown |
| HY-149634 |
PI3Kδ-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-150034 |
PI3K-IN-38 |
Inhibitor |
/ |
Unkown |
| HY-150061 |
NVP-BBD130 |
Inhibitor |
/ |
Unkown |
| HY-150587 |
Anti-inflammatory agent 31 |
Inhibitor |
/ |
Unkown |
| HY-150638 |
PI3Kδ/γ-IN-3 |
|
/ |
Unkown |
| HY-151635 |
PI3K/VEGFR2-IN-1 |
|
/ |
Unkown |
| HY-151915 |
ATR-IN-20 |
Inhibitor |
/ |
Unkown |
| HY-152238 |
PI3K/mTOR Inhibitor-12 |
Inhibitor |
/ |
Unkown |
| HY-15268 |
PP487 |
Inhibitor |
/ |
Unkown |
| HY-152774 |
Antitumor agent-86 |
Inhibitor |
/ |
Unkown |
| HY-153120 |
PI3K/mTOR Inhibitor-13 |
Inhibitor |
/ |
Unkown |
| HY-153703 |
PI3Kγ inhibitor 7 |
Inhibitor |
/ |
Unkown |
| HY-153915 |
PI3Kα-IN-11 |
Inhibitor |
95.35% |
Unkown |
| HY-155124 |
Antiproliferative agent-32 |
Inducer |
/ |
Unkown |
| HY-155180 |
FD2056 |
Inhibitor |
/ |
Unkown |
| HY-155570 |
Anticancer agent 137 |
|
/ |
Unkown |
| HY-155730 |
PI3K-IN-41 |
Inhibitor |
/ |
Unkown |
| HY-155833 |
PI3Kδ-IN-13 |
Inhibitor |
/ |
Unkown |
| HY-155890 |
Fimepinostat mesylate |
|
/ |
Unkown |
| HY-155975 |
PI3Kδ-IN-14 |
Inhibitor |
/ |
Unkown |
| HY-155996 |
FD2157 |
|
/ |
Unkown |
| HY-156018 |
PI3Kα-IN-13 |
Inhibitor |
/ |
Unkown |
| HY-156080 |
PI3K-IN-48 |
Inhibitor |
/ |
Unkown |
| HY-156091 |
PI3Kα/HDAC6-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-15643B |
LY 303511 dihydrochloride |
|
/ |
Unkown |
| HY-156445 |
PI3K/mTOR Inhibitor-14 |
Inhibitor |
/ |
Unkown |
| HY-157125 |
PI3Kα-IN-14 |
|
/ |
Unkown |
| HY-157128 |
PI3Kδ-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-157295 |
PI3K/HDAC-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-157319 |
PI3Kα-IN-15 |
Inhibitor |
/ |
Unkown |
| HY-157648 |
18:0-20:4 PI(3)P ammonium |
|
/ |
Unkown |
| HY-157652 |
18:0-20:4 PI(3,4,5)P3 |
|
/ |
Unkown |
| HY-157707 |
18:1 PI(3,4,5)P3 |
|
/ |
Unkown |
| HY-157714 |
08:0 PI(3,4)P2 |
|
/ |
Unkown |
| HY-158017 |
WXM-1-170 |
|
/ |
Unkown |
| HY-158029 |
PI3Kα-IN-21 |
|
/ |
Unkown |
| HY-158050 |
PXB17 |
Inhibitor |
/ |
Unkown |
| HY-158147 |
PI3Kδ-IN-20 |
Inhibitor |
/ |
Unkown |
| HY-158156 |
NF-κB-IN-16 |
|
/ |
Unkown |
| HY-158688 |
PI3Kδ-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-159510 |
VEGFR-2-IN-51 |
|
/ |
Unkown |
| HY-159517 |
PI3K/Akt/mTOR-IN-5 |
|
/ |
Unkown |
| HY-159577 |
Nic-15 |
Modulator |
/ |
Unkown |
| HY-159892 |
PD-1/PD-L1-IN-54 |
|
/ |
Unkown |
| HY-160282 |
PI3K-IN-49 |
Inhibitor |
/ |
Unkown |
| HY-160283 |
PI3K-IN-50 |
Inhibitor |
/ |
Unkown |
| HY-160418 |
PI3K-IN-51 |
Inhibitor |
/ |
Unkown |
| HY-160864 |
Torbafylline |
Inhibitor |
/ |
Unkown |
| HY-161140 |
PI3Kα-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-161144 |
AKT-IN-21 |
|
/ |
Unkown |
| HY-161301 |
PI3K-IN-52 |
Inhibitor |
/ |
Unkown |
| HY-161362 |
SR-3-65 |
|
/ |
Unkown |
| HY-161373 |
PI3Kα-IN-22 |
Inhibitor |
/ |
Unkown |
| HY-161816 |
PI3K/AKT-IN-3 |
|
/ |
Unkown |
| HY-161852 |
PI3K-IN-55 |
|
/ |
Unkown |
| HY-161858 |
EpskA21 |
|
/ |
Unkown |
| HY-161874 |
RPS6-IN-1 |
|
/ |
Unkown |
| HY-161968 |
EGFR/PI3Kα-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-162268 |
MALT1-IN-13 |
|
/ |
Unkown |
| HY-162292 |
Anticancer agent 190 |
Inhibitor |
/ |
Unkown |
| HY-162647 |
PI3Kδ-IN-22 |
Inhibitor |
/ |
Unkown |
| HY-162802 |
PI3K/AKT-IN-4 |
|
/ |
Unkown |
| HY-162848 |
IHMT-PI3K-315 |
Inhibitor |
/ |
Unkown |
| HY-163151 |
JE-133 |
Inhibitor |
/ |
Unkown |
| HY-16332 |
ML-220 |
|
/ |
Unkown |
| HY-163360 |
PI3Kα-IN-19 |
Inhibitor |
/ |
Unkown |
| HY-163361 |
PI3Kα-IN-20 |
Inhibitor |
/ |
Unkown |
| HY-163501 |
PI3Kα-IN-23 |
Inhibitor |
/ |
Unkown |
| HY-163511 |
PI3K/Akt/mTOR-IN-4 |
|
/ |
Unkown |
| HY-163533 |
CPD-002 |
Inhibitor |
/ |
Unkown |
| HY-163538 |
TYM-3-98 |
|
99.56% |
Unkown |
| HY-16461 |
Solenopsin |
|
/ |
Unkown |
| HY-165394 |
Melafolone |
Inhibitor |
/ |
Unkown |
| HY-16769 |
Panulisib |
|
/ |
Unkown |
| HY-168319 |
PI3Kγ ligand 1 |
|
/ |
Unkown |
| HY-168609 |
CRI9 |
|
/ |
Unkown |
| HY-168718 |
FAK-IN-22 |
|
/ |
Unkown |
| HY-168858 |
TRK-IN-30 |
Inhibitor |
/ |
Unkown |
| HY-168893 |
K882 |
|
/ |
Unkown |
| HY-168919 |
KRASG12C IN-16 |
|
/ |
Unkown |
| HY-169019 |
XJTU-L453 |
|
/ |
Unkown |
| HY-169100 |
Antiproliferative agent-57 |
Inhibitor |
/ |
Unkown |
| HY-169403 |
NW16 |
|
/ |
Unkown |
| HY-169413 |
AKT-IN-25 |
Inhibitor |
/ |
Unkown |
| HY-169983 |
PI3Kδ-IN-23 |
Inhibitor |
/ |
Unkown |
| HY-170648 |
TS-IN-5 |
|
/ |
Unkown |
| HY-170656 |
PI3K/mTOR Inhibitor-17 |
Inhibitor |
/ |
Unkown |
| HY-170877 |
SHP2-IN-35 |
|
/ |
Unkown |
| HY-170912 |
Topo I/II-IN-2 |
|
/ |
Unkown |
| HY-171558 |
PI3K-IN-56 |
Inhibitor |
/ |
Unkown |
| HY-171777 |
Erufosine |
Inhibitor |
/ |
Unkown |
| HY-172130 |
PI3Kδ/BET-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-172139 |
PI3Kα-IN-25 |
Inhibitor |
/ |
Unkown |
| HY-172175 |
HYS-072 |
|
/ |
Unkown |
| HY-172201 |
NF-κB-IN-19 |
|
/ |
Unkown |
| HY-172255 |
PI4KIII beta inhibitor 4 |
|
/ |
Unkown |
| HY-172256 |
PI4KIII beta inhibitor 5 |
Inhibitor |
/ |
Unkown |
| HY-172259 |
Toyaburgine |
Inhibitor |
/ |
Unkown |
| HY-172620 |
LIB3S0280 |
|
99.89% |
Unkown |
| HY-172771 |
Multi-target kinase inhibitor 4 |
Inhibitor |
/ |
Unkown |
| HY-172784 |
Anticancer agent 273 |
|
/ |
Unkown |
| HY-172785 |
PI3K-IN-57 |
Inhibitor |
/ |
Unkown |
| HY-172886 |
PI3K-IN-58 |
|
/ |
Unkown |
| HY-172889 |
PI3K/HDAC-IN-4 |
|
/ |
Unkown |
| HY-172892 |
PI3K-IN-59 |
Inhibitor |
/ |
Unkown |
| HY-172964 |
KIM-161 |
|
/ |
Unkown |
| HY-173005 |
JZ19 |
Inhibitor |
/ |
Unkown |
| HY-173007 |
ALK/PI3K/AKT-IN-1 |
|
/ |
Unkown |
| HY-173165 |
OA-Br-1 |
|
/ |
Unkown |
| HY-173367 |
Anticancer agent 271 |
Inhibitor |
/ |
Unkown |
| HY-173368 |
Antiproliferative agent-67 |
Inhibitor |
/ |
Unkown |
| HY-173493 |
ALK-IN-31 |
|
/ |
Unkown |
| HY-174306 |
MARY1 |
|
/ |
Unkown |
| HY-174321 |
A2073 |
Inhibitor |
/ |
Unkown |
| HY-174324 |
VEGFR-2/P-gp-IN-1 |
|
/ |
Unkown |
| HY-174379 |
KRAS IN-44 |
|
/ |
Unkown |
| HY-174396 |
PI3Kδ/HDAC6-IN-1 |
|
/ |
Unkown |
| HY-174469 |
PROTAC PI3K/110β degrader-2 |
|
/ |
Unkown |
| HY-174855 |
PI3K/mTOR-IN-17 |
|
/ |
Unkown |
| HY-175002 |
PI3Kδ-IN-24 |
|
/ |
Unkown |
| HY-175068 |
D-myo-Inositol-1,3,4,5,6-pentaphosphate sodium |
|
/ |
Unkown |
| HY-175317 |
Nogo-B-IN-1 |
|
/ |
Unkown |
| HY-175369 |
PI3Kδ-IN-25 |
Inhibitor |
/ |
Unkown |
| HY-175734 |
PI3Kδ-IN-26 |
Inhibitor |
/ |
Unkown |
| HY-175874 |
Tubulin-IN-55 |
|
/ |
Unkown |
| HY-176239 |
PROTAC PI3Kδ degrader-1 |
|
/ |
Unkown |
| HY-176281 |
PI3Kα-IN-26 |
Inhibitor |
/ |
Unkown |
| HY-176421 |
PROTAC PI3K/110β degrader-1 |
Degrader |
/ |
Unkown |
| HY-17651 |
PI3K-IN-60 |
Inhibitor |
/ |
Unkown |
| HY-176854 |
PI3K/mTOR-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-177149 |
Allantoin ascorbate |
|
/ |
Unkown |
| HY-177270 |
CHNQD-01281 |
Modulator |
/ |
Unkown |
| HY-177277 |
HM5023507 |
Inhibitor |
/ |
Unkown |
| HY-177277A |
(R)-HM5023507 |
Inhibitor |
/ |
Unkown |
| HY-177762 |
Pan-RAS-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-177908 |
SH-273 |
|
/ |
Unkown |
| HY-178304S |
L-Valine-d7 |
|
/ |
Unkown |
| HY-178305S |
L-Valine-d |
|
/ |
Unkown |
| HY-178371 |
PI3KC2γ-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-178485 |
SJY26 |
Inhibitor |
/ |
Unkown |
| HY-178812 |
PI3Kα-IN-27 |
|
/ |
Unkown |
| HY-178955 |
EGFR-IN-182 |
|
/ |
Unkown |
| HY-178984 |
PI3Kα-IN-28 |
|
/ |
Unkown |
| HY-178993 |
PI3K/AKT-IN-5 |
|
/ |
Unkown |
| HY-178996 |
FLT3-IN-36 |
|
/ |
Unkown |
| HY-179032 |
VEGFR-2-IN-77 |
|
/ |
Unkown |
| HY-179155 |
PI3K/mTOR-IN-19 |
|
/ |
Unkown |
| HY-179424 |
PROTAC HIF-1α degrader-2 |
|
/ |
Unkown |
| HY-179457 |
CC-11 |
Inhibitor |
/ |
Unkown |
| HY-179464 |
CC-M-1 |
Inhibitor |
/ |
Unkown |
| HY-179498 |
ROCK2-IN-13 |
|
/ |
Unkown |
| HY-179623 |
PI3Kα-IN-29 |
|
/ |
Unkown |
| HY-180112 |
SH543 |
|
/ |
Unkown |
| HY-180192 |
Dehydroxy-oridonin-vinyl ester |
|
/ |
Unkown |
| HY-180261 |
GP262 |
|
/ |
Unkown |
| HY-180281 |
PLAGL2-IN-1 |
|
/ |
Unkown |
| HY-180556 |
PI3K/mTOR-IN-20 |
Inhibitor |
/ |
Unkown |
| HY-180853 |
PI3K/Akt/mTOR-IN-6 |
|
/ |
Unkown |
| HY-181015 |
α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu |
|
/ |
Unkown |
| HY-181093 |
EGFR-IN-191 |
|
/ |
Unkown |
| HY-181097 |
EGFR-IN-192 |
|
/ |
Unkown |
| HY-181099 |
EGFR WT/T790M-IN-4 |
|
/ |
Unkown |
| HY-181150 |
Hit20 |
Inhibitor |
/ |
Unkown |
| HY-181153 |
PROTAC FGFR3 Degrader-1 |
Degrader |
/ |
Unkown |
| HY-181479 |
EGFR-IN-196 |
|
/ |
Unkown |
| HY-181581 |
IMM-H012 |
Inhibitor |
/ |
Unkown |
| HY-181670 |
WH23 |
|
/ |
Unkown |
| HY-181672 |
PI3K/AKT/ERK/CREB activator 1 |
Activator |
/ |
Unkown |
| HY-181710 |
LASSBio-2337 |
Inhibitor |
/ |
Unkown |
| HY-181741 |
PI3K-001 |
|
/ |
Unkown |
| HY-181801 |
FASN-IN-8 |
|
/ |
Unkown |
| HY-181833 |
PI3K/PIKK-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-181855 |
PI3K/PIKK-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-181883 |
KRAS-IN-55 |
Inhibitor |
/ |
Unkown |
| HY-182003 |
Anticancer agent 308 |
Inhibitor |
/ |
Unkown |
| HY-182066 |
Photosensitizer-9 |
Activator |
/ |
Unkown |
| HY-182083 |
PROTAC PI3Kα/δ degrader-1 |
Degrader |
/ |
Unkown |
| HY-182086 |
Copanlisib-NH |
Ligand |
/ |
Unkown |
| HY-182236 |
JRN73958 |
|
/ |
Unkown |
| HY-182282 |
PI3K/AKT-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-182368 |
PI3Kα-IN-30 |
|
/ |
Unkown |
| HY-182614 |
BJ-2302 |
Inhibitor |
/ |
Unkown |
| HY-182671 |
SRX3305 |
|
/ |
Unkown |
| HY-182693 |
CPL302-253 |
Inhibitor |
/ |
Unkown |
| HY-182946 |
PI3Kα-IN-31 |
Inhibitor |
/ |
Unkown |
| HY-183068 |
AP4-43 |
Inhibitor |
/ |
Unkown |
| HY-183069 |
FKL-137 |
|
/ |
Unkown |
| HY-183272 |
PI3K/Akt/mTOR-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-183285 |
PI3Kα-IN-32 |
Inhibitor |
/ |
Unkown |
| HY-183316 |
Anticancer agent 319 |
|
/ |
Unkown |
| HY-183327 |
PI3K/mTOR-IN-22 |
Inhibitor |
/ |
Unkown |
| HY-183741 |
VVD-844 |
Inhibitor |
/ |
Unkown |
| HY-183770 |
LCI40 |
Inhibitor |
/ |
Unkown |
| HY-183787 |
PI3Kα-IN-33 |
|
/ |
Unkown |
| HY-185205 |
VVD-484 |
Inhibitor |
/ |
Unkown |
| HY-185460 |
Pertuzumab-LD3 |
Inhibitor |
/ |
Unkown |
| HY-19535B |
Nemiralisib succinate |
Inhibitor |
/ |
Unkown |
| HY-19719B |
Miransertib mesylate |
Inhibitor |
/ |
Unkown |
| HY-48869 |
PI3K-IN-46 |
|
98.0% |
Unkown |
| HY-B0093AS |
Benazepril-d5 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-B1203S1 |
Fludrocortisone-d2 |
|
/ |
Unkown |
| HY-B1550S |
Benzoin-d10 |
Inhibitor |
/ |
Unkown |
| HY-B1885S |
Fenitrothion-d6 |
|
/ |
Unkown |
| HY-E70609 |
PIK3CG Recombinant Human Active Lipid Kinase |
|
/ |
Unkown |
| HY-E70631 |
PIP5K1A Recombinant Human Active Lipid Kinase |
|
/ |
Unkown |
| HY-E70789 |
BCR-RET Recombinant Human Active Protein Kinase |
|
/ |
Unkown |
| HY-E70855 |
PKCζ Recombinant Human Active Protein Kinase |
|
/ |
Unkown |
| HY-G0007S |
Omeprazole sulfone-d3 |
Control |
/ |
Unkown |
| HY-G0007S1 |
Omeprazole sulfone-13C,d3 |
Control |
/ |
Unkown |
| HY-N0361S |
Dihydrocapsaicin-d3 |
|
/ |
Unkown |
| HY-N0392R |
Polygalasaponin F (Standard) |
Inhibitor |
/ |
Unkown |
| HY-N0448R |
10-Gingerol (Standard) |
|
/ |
Unkown |
| HY-N0479S |
Licarin B-d4 |
|
/ |
Unkown |
| HY-N0660R |
Jujuboside B (Standard) |
|
/ |
Unkown |
| HY-N0717S2 |
L-Valine-13C5,15N,d8 |
|
99.3% |
Unkown |
| HY-N0717S3 |
L-Valine-13C5,15N,d2 |
|
/ |
Unkown |
| HY-N0717S5 |
L-Valine-2-13C |
|
/ |
Unkown |
| HY-N0717S8 |
L-Valine-d1 |
|
98.0% |
Unkown |
| HY-N0717S9 |
L-Valine-15N,d8 |
|
/ |
Unkown |
| HY-N0776R |
Isorhamnetin (Standard) |
Inhibitor |
/ |
Unkown |
| HY-N10106 |
Dihydromyristicin |
Inhibitor |
/ |
Unkown |
| HY-N10342 |
Cajanol |
|
/ |
Unkown |
| HY-N10802 |
6-O-Isobutyrylbritannilactone |
Inhibitor |
98.34% |
Unkown |
| HY-N12489 |
Ishophloroglucin A |
|
/ |
Unkown |
| HY-N1255A |
Scoulerine hydrochloride |
|
/ |
Unkown |
| HY-N12959 |
5,4'-Dihydroxy-6,8-dimethoxy-7-O-rhamnosyl flavone |
Inhibitor |
/ |
Unkown |
| HY-N13063 |
Anticancer agent 235 |
|
/ |
Unkown |
| HY-N1338 |
Royleanone |
Inhibitor |
/ |
Unkown |
| HY-N15902 |
BODIPY 505/515 TMR PI(3,4,5)P3 ammonium |
|
/ |
Unkown |
| HY-N15977 |
18:1-6:0 Biotin PI(3,5)P2 ammonium) |
|
/ |
Unkown |
| HY-N16118 |
Asperosaponin V |
Modulator |
/ |
Unkown |
| HY-N18161 |
Isopsoralidin |
Inhibitor |
/ |
Unkown |
| HY-N3000A |
6-Methoxydihydrosanguinarine hydrochloride |
|
/ |
Unkown |
| HY-N8931 |
Monomethyl lithospermate |
Activator |
/ |
Unkown |
| HY-N9602 |
6,7,4'-Trihydroxyflavanone |
|
/ |
Unkown |
| HY-N9980 |
Antcin K |
Inhibitor |
/ |
Unkown |
| HY-P0175A |
740 Y-P TFA |
|
/ |
Unkown |
| HY-P10093 |
Penetratin-PI3Kγ(126-150) |
Inhibitor |
/ |
Unkown |
| HY-P10320 |
T3 Peptide |
Activator |
/ |
Unkown |
| HY-P10833 |
C-VGB3 |
|
/ |
Unkown |
| HY-P10981 |
ErbB2 peptide |
Ligand |
/ |
Unkown |
| HY-P10992 |
YVPGP |
|
/ |
Unkown |
| HY-P11130 |
LQEQ-19 (mouse, rat) |
Activator |
/ |
Unkown |
| HY-P11313 |
Catestatin (rat) |
|
/ |
Unkown |
| HY-P4790 |
Acetyl-Exenatide |
Inhibitor |
/ |
Unkown |
| HY-RS10463 |
PI3 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W009141S |
1-Monopalmitin-d31 |
|
/ |
Unkown |
| HY-W010201S1 |
Citronellol-d3 |
|
/ |
Unkown |
| HY-W711035 |
Picolinafen |
|
/ |
Unkown |
| HY-W714183 |
Dinitramine |
|
/ |
Unkown |
| HY-W783478 |
Calebin A |
Inhibitor |
/ |
Unkown |
| HY-W934539 |
Lenalidomide-amide-C8-Br |
|
/ |
Unkown |
| HY-W940885 |
Pomalidomide-NH-C13-OH |
|
/ |
Unkown |
| HY-100603B |
(R)-GSK-F1 |
Inhibitor |
/ |
Unkown |
| HY-10202B |
Tandutinib sulfate |
|
/ |
Unkown |
| HY-10549 |
PI3Kγ inhibitor 1 |
Inhibitor |
/ |
Unkown |
| HY-107216A |
(3aS,4R,9bR)-G-1 |
|
/ |
Unkown |
| HY-110038 |
FTI-277 TFA |
|
/ |
Unkown |
| HY-113308AS1 |
Taurolithocholic Acid-d5 sodium salt |
|
/ |
Unkown |
| HY-113402AR |
Gamma-glutamylcysteine TFA (Standard) |
|
/ |
Unkown |
| HY-113402B |
Gamma-glutamylcysteine ammonium |
|
/ |
Unkown |
| HY-114457 |
Phosphatidylinositol 4,5-bisphosphate |
Substrate |
/ |
Unkown |
| HY-116191 |
WJD008 |
Inhibitor |
/ |
Unkown |
| HY-116563 |
PI3Kα-IN-24 |
Inhibitor |
/ |
Unkown |
| HY-117885 |
PF-5177624 |
Inhibitor |
/ |
Unkown |
| HY-117923 |
PF-06465603 |
Inhibitor |
/ |
Unkown |
| HY-118236 |
(S)-AZD 6482 |
|
/ |
Unkown |
| HY-118374 |
AM-9635 |
Inhibitor |
/ |
Unkown |
| HY-120471 |
AM-0687 |
Inhibitor |
/ |
Unkown |
| HY-121672 |
PI3K-IN-7 |
|
/ |
Unkown |
| HY-121684 |
Ramentaceone |
|
/ |
Unkown |
| HY-123790 |
AS2541019 |
Inhibitor |
/ |
Unkown |
| HY-12491 |
PIK-C98 |
|
/ |
Unkown |
| HY-12517 |
GNE-293 |
Inhibitor |
/ |
Unkown |
| HY-128393S1 |
Trilinolein-13C54 |
|
/ |
Unkown |
| HY-136700 |
SB-699551 free base |
|
/ |
Unkown |
| HY-143277 |
HL-2 |
|
/ |
Unkown |
| HY-148965A |
PtdIns-(3)-P1 (1,2-dipalmitoyl) ammonium |
|
/ |
Unkown |
| HY-150309 |
PI3K-IN-54 |
Inhibitor |
/ |
Unkown |
| HY-15288 |
PI3kδ inhibitor 1 |
Inhibitor |
/ |
Unkown |
| HY-155211 |
mTOR inhibitor-13 |
Inhibitor |
/ |
Unkown |
| HY-15643 |
LY 303511 |
|
/ |
Unkown |
| HY-156484 |
SPR519 |
Inhibitor |
/ |
Unkown |
| HY-157287 |
(S)-Phe-A110/B319 |
|
/ |
Unkown |
| HY-157288 |
(R)-Phe-A110/B319 |
|
/ |
Unkown |
| HY-157706 |
PI(3,4)P2 (18:1) ammonium salt |
Activator |
/ |
Unkown |
| HY-160458 |
PI3Kα-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-16122 |
CAL-130 Racemate |
Inhibitor |
/ |
Unkown |
| HY-16122A |
CAL-130 |
Inhibitor |
/ |
Unkown |
| HY-162023 |
mTOR inhibitor-10 |
Inhibitor |
/ |
Unkown |
| HY-162024 |
mTOR inhibitor-16 |
Inhibitor |
/ |
Unkown |
| HY-162025 |
mTOR inhibitor-17 |
Inhibitor |
/ |
Unkown |
| HY-164384 |
DFX117 |
|
/ |
Unkown |
| HY-164548 |
WK88-1 |
|
/ |
Unkown |
| HY-164662 |
mTOR inhibitor-24 |
Inhibitor |
/ |
Unkown |
| HY-167952 |
mTOR inhibitor-25 |
|
/ |
Unkown |
| HY-172742 |
Dioctanoyl PI(3,4)P2 sodium |
|
/ |
Unkown |
| HY-174645 |
Human IL10RA mRNA |
|
/ |
Unkown |
| HY-175083 |
PtdIns-(4,5)-P2-biotin trisodium |
Substrate |
/ |
Unkown |
| HY-175086 |
PtdIns-(3,4,5)-P3-fluorescein triethylammonium |
|
/ |
Unkown |
| HY-175089 |
PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) sodium |
|
/ |
Unkown |
| HY-175407 |
18:0-20:4 PI(3,4,5)P3 sodium |
|
/ |
Unkown |
| HY-175862 |
ALR2-IN-9 |
|
/ |
Unkown |
| HY-176832 |
PtdIns-(3,4)-P2 (1,2-dipalmitoyl) sodium |
|
/ |
Unkown |
| HY-178445 |
PI3Kδ-IN-27 |
Inhibitor |
/ |
Unkown |
| HY-178775 |
PI4K-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-179554 |
PtdIns-(4,5)-P2-fluorescein triethylammonium |
|
/ |
Unkown |
| HY-181963 |
ZINC-1000507824 |
|
/ |
Unkown |
| HY-185185 |
S58 aptamer |
|
/ |
Unkown |
| HY-185456 |
PI3K/mTOR-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-185457 |
BrAC-GGFG-Aminal-PI3K/mTOR-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-90003S |
Tianeptine-d12 |
|
/ |
Unkown |
| HY-B0965S |
Thioridazine 2-Sulfone-d3 |
|
/ |
Unkown |
| HY-B1234S |
Octinoxate-13C,d3 |
|
/ |
Unkown |
| HY-N0143R |
Phlorizin (Standard) |
|
/ |
Unkown |
| HY-N0493R |
Pectolinarigenin (Standard) |
|
/ |
Unkown |
| HY-N0699R |
Daphnoretin (Standard) |
|
/ |
Unkown |
| HY-N0717S7 |
L-Valine-1-13C,15N |
|
/ |
Unkown |
| HY-N0819R |
Raddeanin A (Standard) |
Inducer |
/ |
Unkown |
| HY-N10133 |
Licoflavanone |
|
/ |
Unkown |
| HY-N12531 |
Molephantin |
|
/ |
Unkown |
| HY-N13164 |
Polygalacin D3 |
|
/ |
Unkown |
| HY-N1431A |
Tabersonine hydrochloride |
|
98.55% |
Unkown |
| HY-N2037AS1 |
Higenamine-d4-1 hydrochloride |
|
/ |
Unkown |
| HY-N4189 |
Isocucurbitacin B |
|
98.98% |
Unkown |
| HY-N6926 |
1,3,5-Tricaffeoylquinic acid |
|
/ |
Unkown |
| HY-N8380 |
(-)-Latifolin |
|
/ |
Unkown |
| HY-N9164 |
Hecubine |
|
/ |
Unkown |
| HY-P10393 |
ERα17p |
Inducer |
/ |
Unkown |
| HY-W010201S |
Citronellol-d6 |
Activator |
/ |
Unkown |
| HY-W075770 |
Nickel(II) oxide |
|
≥99.0% |
Unkown |
| HY-W636234 |
GSK2636771 methyl |
Inhibitor |
/ |
Unkown |
| HY-W714214 |
Ethalfluralin |
|
/ |
Unkown |
| HY-W937057 |
(S,R,S)-AHPC-Me-10-bromodecanoic acid |
|
/ |
Unkown |
| HY-Y1177R |
Diphenyl disulfide (Standard) |
|
/ |
Unkown |
| HY-122593 |
PI3Kδ-IN-5 |
Inhibitor |
99.62% |
Unkown |
| HY-18310 |
NIBR-17 |
Inhibitor |
98.00% |
Unkown |